Ame, Jumatiya .

HRN: 28-64-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/03/2026
03/10/2026
IV
500
Q6
S/P NIV
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: